Tilray medical launches broken coast medical cannabis brand in australia

New york and sydney, june 20, 2024 (globe newswire) -- tilray medical, a division of tilray brands, inc. ("tilray brands") (nasdaq: tlry and tsx: tlry) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, thereby transforming healthcare, today announced the launch of broken coast eu-gmp certified medical cannabis products in australia. denise faltischek, chief strategy officer and head of international, tilray brands, said, “our highly scalable global footprint, which enables us to deliver medical cannabis globally from our facilities in canada as well as our facilities in europe, combined with our diverse portfolio of cannabis brands and products have been instrumental in leading the evolution of the global medical cannabis industry.
TLRY Ratings Summary
TLRY Quant Ranking